In addition, in an in vivo mouse model of GBM, Hsp90 suppression synergistically lowers tumor development and survival after radiation therapy (CBCT-based irradiation) while also decreasing irradiation-induced GBM cell migration and tumor invasiveness [70]. The gene discussed is HSP90AA1; the disease is glioblastoma.